Is Now the Time to Invest in Accelerate Diagnostics Inc. (NASDAQ:AXDX)?

Is Now the Time to Invest in Accelerate Diagnostics Inc. (NASDAQ:AXDX)?

SHARE

The Accelerate Diagnostics Inc. (AXDX) shares are trading at higher $12.89 and the avg recommendation for the stock is Moderate Buy. The current analyst price target stands at $13.50.

To add more color to this target, the company’s high over the last year is $24.00 and the low is $4.53. Over the last 52 weeks, AXDX is down -46.29% while the S&P 500 is up 1.07%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, AXDX reported a profit of $1.05 million. Accelerate Diagnostics Inc. also saw revenues increase to $2.34 million. In addition, AXDX has free cash flow of -$18.04 million as of 03-2020 The company’s EBITDA came in at -$14.3 million which compares well with its peers.

AXDX Return on Assets is -59.90%. All told, it is clear that, AXDX needs to be on your watchlist.

Find out when AXDX reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. AXDX has a short ratio of 34.99 and outstanding shares of 54.84M.

Company Outlook

AXDX has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 0.7 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -1.54. Accelerate Diagnostics Inc. AXDX also noted assets of $119.99 million at the end of the last quarter. Investors should also keep an eye on sector updates as AXDX has historically followed its peers on positive news.

All told, Accelerate Diagnostics Inc. AXDX has strung together solid data and demonstrated underlying fundamentals. At its current valuation, AXDX represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

Accelerate Diagnostics Inc. AXDX is now commanding a market cap of 757.67M and a float of 32.17M. AXDX is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of AXDX stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in AXDX, either long or short, and we have not been compensated for this article.